Yabe D, Nakamura J, Kaneto H et al (2020) Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
Remove the vial or pen from cold storage 1520 minutes before injection to allow it to reach room temperature, which reduces injection discomfort and improves medication absorption
For gastrointestinal side effects, eating smaller, more frequent meals and avoiding large or high-fat meals may help
It is supplied for in-vitro and laboratory research use only
If you want more detailed guidance on protein intake while taking GLP-1 medications, our muscle and protein planner provides it
Dr Andronis echoed the sentiment that the research is promising but noted the small cohort and limited focus of the study